SCLC
Ongoing protocols: click on the protocol for the inclusion and exclusion criteria (update 15/11/2019)
Non-metastatic stage
Currently no trials
Metastatic stage
Metastatic stage
1st line
Currently no trials
2nd line
Currently no trials
3th line
JZHB (Lilly)
A phase 1b study of LY3295668 Erbumine Monotherapy in Patients With Platinum-Sensitive, Extenstive-Stage SCLC.
2nd line
Currently no trials
3th line
JZHB (Lilly)
A phase 1b study of LY3295668 Erbumine Monotherapy in Patients With Platinum-Sensitive, Extenstive-Stage SCLC.